PŘEHLEDOVÉ ČLÁNKY Bariéry při odvykání kouření u pacientů s diabetes mellitus 460 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2025;71(7):456-460 / www.casopisvnitrnilekarstvi.cz 20. Wakefield M, Roberts L, Rosenfeld E. Prospects for smoking cessation among people with insulindependent diabetes. Patient Educ Couns. 1998;34(3):257266. 21. Ohkuma T, Iwase M, Fujii H, Kaizu S, Ide H, Jodai T, Kikuchi Y, Idewaki Y, Hirakawa Y, Nakamura U, Kitazono T. Dose and timedependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. PLoS One. 2015;10(3):e0122023. 22. Driva S, Korkontzelou A, Tonstad S, Tentolouris N, Litsiou E, Vasileiou V, Vassiliou AG, Saltagianni V, Katsaounou P. Metabolic changes following smoking cessation in patients with type 2 diabetes mellitus. Biomedicines. 2024;12(8):1882. 23. Chen Z, Liu XA, Kenny PJ. Central and peripheral actions of nicotine that influence blood glucose homeostasis and the development of diabetes. Pharmacol Res. 2023;194:106860. 24. Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention. World J Diabetes. 2021;12(12):20362049. 25. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315327. 26. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):22952303. 27. Adu MD, Malabu UH, MalauAduli AEO, MalauAduli BS. Enablers and barriers to effective diabetes selfmanagement: A multinational investigation. PLoS One. 2019;14(6):e0217771. 28. Kristensen PL, PedersenBjergaard U, Thorsteinsson B. Varenicline may trigger severe hypoglycaemia in Type 1 diabetes. Diabet Med. 2008;25(5):625626. 29. Russo C, Walicka M, Caponnetto P, Cibella F, Maglia M, Alamo A, Campagna D, Frittitta L, Di Mauro M, Caci G, Krysinski A, Franek E, Polosa R. Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: a randomized clinical trial. JAMA Netw Open. 2022;5(6):e2217709. 30. Javelot H, Westphal JF, Socha M, Vasselon P, Germain N, Baratta A, Nonnenmacher C, Messaoudi M, Böhme P, Javelot T. Report of a glycemic imbalance in a diabetic patient after initiation of nicotine replacement therapy. J Pharm Clin. 2009;28:193198. 31. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, Dallosso HM, Daly H, Doherty Y, Eaton S, Fox C, Oliver L, Rantell K, Rayman G, Khunti K. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008;336(7642):491495. Erratum in: BMJ. 2008;336(7649). 32. American Diabetes Association Professional Practice Committee. Facilitating positive health behaviors and wellbeing to improve health outcomes: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Supplement_1):S86S127. 33. Nagrebetsky A, Brettell R, Roberts N, Farmer A. Smoking cessation in adults with diabetes: a systematic review and metaanalysis of data from randomised controlled trials. BMJ Open. 2014;4(3):e004107. 34. Singh D, Saadabadi A. Varenicline. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. 35. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;(3):CD008286. 36. European Medicines Agency. Champix – supply shortage. Amsterdam: EMA; 2021 Jul 8 [Internet]. EMA; 2025 [cited 2025 Oct 8]. Available from: https://www.ema.europa.eu/en/medicines/human/shortages/champix 37. Puljević C, Stjepanović D, Meciar I, Kang H, Chan G, Morphett K, Bendotti H, Kunwar G, Gartner C. Systematic review and metaanalyses of cytisine to support tobacco cessation. Addiction. 2024;119(10):17131725. 38. Lycett D, Nichols L, Ryan R, Farley A, Roalfe A, Mohammed MA, Szatkowski L, Coleman T, Morris R, Farmer A, Aveyard P. The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. Lancet Diabetes Endocrinol. 2015;3(6):423430. 39. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152(1):1017. 40. Grech J, Norman IJ, Sammut R. Exploring the smoking cessation needs of individuals with diabetes using the InformationMotivationBehavior Skills model. Tob Prev Cessat. 2024;10. 41. Národní linka pro odvykání kouření. Národní linka pro odvykání | 800 350 000. Praha: Národní linka pro odvykání kouření; [Internet]. [cited 2025 Oct 8]. Available from: https:// www.chciodvykat.cz/odvykani-koureni 42. Společnost pro léčbu závislosti na tabáku. Centra pro závislé na tabáku. Praha: SLZT; [Internet]. [cited 2025 Oct 8]. Available from: https://www.slzt.cz/centra/centra-pro-zavisle-na-tabaku 43. Česká diabetologická společnost. Diabetes mellitus (cukrovka) a kouření. Praha: ČDS; [Internet]. [cited 2025 Oct 8]. Available from: https://www.diab.cz/wp-content/uploads/ dokumenty/Letak_DM_a_koureni.pdf 44. Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):6471. 45. Durlach V, Vergès B, AlSalameh A, Bahougne T, Benzerouk F, Berlin I, Clair C, Mansourati J, Rouland A, Thomas D, Thuillier P, Tramunt B, Le Faou AL. Smoking and diabetes interplay: A comprehensive review and joint statement. Diabetes Metab. 2022;48(6):101370. 46. ZamaniAlavijeh F, Araban M, Koohestani HR, Karimy M. The effectiveness of stress management training on blood glucose control in patients with type 2 diabetes. Diabetol Metab Syndr. 2018;10:39. 47. Surwit RS, van Tilburg MA, Zucker N, McCaskill CC, Parekh P, Feinglos MN, Edwards CL, Williams P, Lane JD. Stress management improves longterm glycemic control in type 2 diabetes. Diabetes Care. 2002;25(1):3034. 48. Attari A, Sartippour M, Amini M, Haghighi S. Effect of stress management training on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2006;73(1):2328. 49. Schoenthaler A, Ogedegbe G, Allegrante JP. Selfefficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009;36(1):127137. 40% 40% 1. zdarma sleva na předplatné našich odborných časopisů zvýhodněný registrační poplatek na většinu kongresů první kongres zdarma VÝHODY PRO LÉKAŘE DO 35 LET Začátky v klinické praxi přinášejí spoustu výzev – od odborného růstu po orientaci v profesním prostředí. Jsme tu pro vás a rádi vám pomůžeme INSTAGRAM solen_cz Vzděláváme, inspirujeme a propojujeme zdravotníky už čtvrt století.
RkJQdWJsaXNoZXIy NDA4Mjc=